|
|
Legal status
Patent in force
| (51) | INT.CL. | C07D 473/00 | (2006.01) |
| A61K 31/52 | (2006.01) | ||
| A61P 35/00 | (2006.01) |
| (11) | Number of the document | 2358710 |
| (13) | Kind of document | T |
| (96) | European patent application number | 09744896.3 |
| Date of filing the European patent application | 2009-11-03 | |
| (97) | Date of publication of the European application | 2011-08-24 |
| (45) | Date of publication and mention of the grant of the patent | 2012-08-15 |
| (46) | Date of publication of the claims translation | 2012-11-26 |
| (86) | Number | PCT/US2009/063020 |
| Date | 2009-11-03 |
| (87) | Number | WO 2010/056563 |
| Date | 2010-05-20 |
| (30) | Number | Date | Country code |
| 113273 P | 2008-11-11 | US |
| (72) |
DALLY, Robert, Dean, US
JOSEPH, Sajan, US
SHEPHERD, Timothy, Alan, US
|
| (73) |
Eli Lilly and Company,
Lilly Corporate Center, Indianapolis, IN 46285,
US
|
| (74) |
Liudmila GERASIMOVIČ,
IĮ "Liudmila Gerasimovič, Patentinis patikėtinis", Vingrių g. 13-42, LT-01141 Vilnius,
LT
|
| (54) | AKT ir P70 S6 kinazės slopikliai |
| AKT AND P70 S6 KINASE INHIBITORS |
| Payment date | Validity (years) | Amount | |
| 2025-10-22 | 17 | 347.00 EUR |
| 2026-11-03 |